- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market.
IOL Chemicals and Pharmaceuticals will host an in-person one-on-one meeting with institutional investors/analysts on September 3, 2026. This event is part of a corporate access program organized by Phillip Capital (India). Discussions will focus on past financial results and information already available in the public domain, without disclosing any unpublished...
IOL Chemicals' Q1 FY27 results are strong: Revenue up 37% to ₹756 Cr, EBITDA up 60.7% to ₹111 Cr (14.6% margin), PAT up 89.9% to ₹64.5 Cr. Growth stems from high capacity use, better product mix & efficiency. Non-ibuprofen APIs soared 67% YoY, now 43% of pharma revenue (target 50-55%...